Impact of Platelet Count on Perioperative Bleeding in Patients With Cirrhosis Undergoing Surgical Treatments of Liver Cancer
In patients with cirrhosis with severe thrombocytopenia (platelet count [PC] <50 × 109/L) and undergoing invasive procedures, it is common clinical practice to increase the PC with platelet transfusions or thrombopoietin receptor agonists to reduce the risk of major periprocedural bleeding. The a...
Main Authors: | Vincenzo Ronca, Matteo Barabino, Roberto Santambrogio, Enrico Opocher, James Hodson, Emanuela Bertolini, Simone Birocchi, Gaetano Piccolo, PierMaria Battezzati, Marco Cattaneo, Gian Marco Podda |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2022-02-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1806 |
Similar Items
-
Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review
by: Simone Birocchi, et al.
Published: (2021-02-01) -
Whole blood platelet aggregation measurement by Multiplate™: potential diagnostic inaccuracy of correcting the results for the sample platelet count
by: Mariangela Scavone, et al.
Published: (2023-12-01) -
Platelet Count/Spleen Thickness Ratio and the Risk of Variceal Bleeding in Cirrhosis With Esophagogastric Varices
by: Huimin Liu, et al.
Published: (2022-07-01) -
Measurement of platelet count with different anticoagulants in thrombocytopenic patients and healthy subjects: accuracy and stability over time
by: Gian Marco Podda, et al.
Published: (2019-12-01) -
Treatment of immune thrombocytopenia (ITP) secondary to malignancy: a systematic review
by: Gian Marco Podda, et al.
Published: (2022-01-01)